Fundz

Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech

PUBLIC · FEMYNov 15, 2023

Round Type

Corporate Round

SuwaneeBiotechnologyHealth CareMedicalMedical Device

Description

Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today announced a strategic upfront investment of $6.85 million by public biotech company, PharmaCyte Biotech, Inc. (Nasdaq: PMCB) and other healthcare investors.

Quick answer

Femasys raised an undisclosed amount in a Corporate Round round, dated November 15, 2023. Femasys is based in Suwanee, Georgia, United States.

How much did Femasys raise?
Femasys raised an undisclosed amount in a Corporate Round round on November 15, 2023.
What does Femasys do?
Femasys Inc. is a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions.
Where is Femasys based and how big is it?
Femasys is based in Suwanee, Georgia, United States. Fundz records about 54 employees.
Who are the decision-makers at Femasys?
Fundz holds 1 contact at Femasys. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Femasys that raised within 45 days of this round, from Fundz verified event records.

  • Nalu Medical raised $115M on December 21, 2023.
  • Procyrion raised $58M on December 13, 2023.
  • Laza Medical raised $36M (Series A) on December 12, 2023.
  • INTRINSIC THERAPEUTICS raised $55M on November 30, 2023.
  • Laza Medical raised $25M on November 24, 2023.
  • Tenon Medical raised $1.3M (Seed) on November 21, 2023.

Who to call at Femasys, and when

A new round usually means Femasys is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Femasys raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Femasys, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Femasys. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Femasys

Location

3950 Johns Creek Court

Suwanee, Georgia, United States

About

Femasys Inc. is a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions. The company has a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Femasys raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts12 people are listed at Femasys. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Femasys's next move

See what Strategic adds

Femasys raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.